Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Adenocarcinoma of Lung × lorlatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Neoadjuvant Non-Small Cell Lung Cancer 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Brain Neoplasms 1 Advanced Non-Small Cell Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

aflutinib 2 lorlatinib 1 anlotinib 1 Orlistat 1 Mastectomy, Segmental 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06858410 2025-03-05

Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma

Guangdong Association of Clinical Trials

Phase 3 Not yet recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡